Lisa Williams: Pharmac director says new lung cancer drug will benefit around 700 people each year
The Mike Hosking Breakfast - A podcast by Newstalk ZB - Thursdays
Game-changing drugs for people with lung cancer. Pharmac has announced its funding of Keytruda and Tecentriq. Those with locally advanced and metastatic non-small cell lung cancer are able to access it from next month. The disease is the leading cause of cancer-related deaths in New Zealand. Director of operations Lisa Williams told Mike Hosking there hasn't been treatment for lung cancer in New Zealand like this. She says they're a new kind of immune checkpoint inhibitors, which will benefit around 700 people each year. LISTEN ABOVE See omnystudio.com/listener for privacy information.
